JANET LABAN: Open Payments
NPI 1154604643 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 32 payments from 10 companies in 2025. Trend: 2023 $156 · 2024 $836 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $167 |
| E.R. Squibb & Sons, L.L.C. | 3 | $158 |
| Merck Sharp & Dohme LLC | 6 | $128 |
| PFIZER INC. | 4 | $74 |
| Novo Nordisk Inc | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| BridgeBio Pharma, Inc. | 1 | $26 |
| Boston Scientific Corporation | 1 | $18 |
| Abbott Laboratories | 1 | $14 |
Products named: REPATHA, CAMZYOS, VERQUVO, Wegovy, ELIQUIS, LEQVIO, VYNDAQEL, Kerendia.
Industry payments across IA — which companies pay providers there.
